Brief: ANG Lifesciences India Says Will Be Able To Surpass Targeted Sales Of 3.5 Bln Rupees In FY 2021-22
19/01/2022 13:48
Jan 19 (Reuters) - ANG Lifesciences India Ltd AGLI.BO :
* ANG LIFESCIENCES INDIA - CO WILL BE ABLE TO SURPASS TARGETED SALES OF 3.5 BILLION RUPEES
IN FY
2021-22
Source text for Eikon: ID:nBSE34PbPQ
Further company coverage: AGLI.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ANG Lifesciences India
See all newsNames Saruchi Gupta As CFO
Brief: Ang Lifesciences India Approved Issue Of Upto 2.2 Million Warrants Convertible Into Shares
Brief: Ang Lifesciences India CFO Subodh Sharma Resigns
Brief: ANG Lifesciences India To Consider Issue Of Bonus Shares
Brief: ANG Lifesciences India Says Will Be Able To Surpass Targeted Sales Of 3.5 Bln Rupees In FY 2021-22